BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 31960340)

  • 1. Impact of Endometriosis Diagnostic Delays on Healthcare Resource Utilization and Costs.
    Surrey E; Soliman AM; Trenz H; Blauer-Peterson C; Sluis A
    Adv Ther; 2020 Mar; 37(3):1087-1099. PubMed ID: 31960340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Healthcare utilization and costs in women diagnosed with endometriosis before and after diagnosis: a longitudinal analysis of claims databases.
    Fuldeore M; Yang H; Du EX; Soliman AM; Wu EQ; Winkel C
    Fertil Steril; 2015 Jan; 103(1):163-71. PubMed ID: 25455535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Healthcare Resource Use and Costs Associated with Opioid Initiation Among Patients with Newly Diagnosed Endometriosis with Commercial Insurance in the USA.
    Estes SJ; Soliman AM; Zivkovic M; Chopra D; Zhu X
    Adv Ther; 2020 Jun; 37(6):2777-2791. PubMed ID: 32399813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Healthcare utilization and cost burden among women with endometriosis by opioid prescription status in the first year after diagnosis: a retrospective claims database analysis.
    As-Sanie S; Soliman AM; Evans K; Erpelding N; Lanier R; Katz NP
    J Med Econ; 2020 Apr; 23(4):371-377. PubMed ID: 31856613
    [No Abstract]   [Full Text] [Related]  

  • 5. Health Care Utilization and Costs Associated with Endometriosis Among Women with Medicaid Insurance.
    Soliman AM; Surrey ES; Bonafede M; Nelson JK; Vora JB; Agarwal SK
    J Manag Care Spec Pharm; 2019 May; 25(5):566-572. PubMed ID: 31039061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-World Evaluation of Direct and Indirect Economic Burden Among Endometriosis Patients in the United States.
    Soliman AM; Surrey E; Bonafede M; Nelson JK; Castelli-Haley J
    Adv Ther; 2018 Mar; 35(3):408-423. PubMed ID: 29450864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of high-risk and chronic opioid use among commercially insured endometriosis patients on health care resource utilization and costs in the United States.
    Estes SJ; Soliman AM; Zivkovic M; Chopra D; Zhu X
    Womens Health (Lond); 2020; 16():1745506520965898. PubMed ID: 33357086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct and Indirect Healthcare Resource Utilization and Costs Among Migraine Patients in the United States.
    Bonafede M; Sapra S; Shah N; Tepper S; Cappell K; Desai P
    Headache; 2018 May; 58(5):700-714. PubMed ID: 29446063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Healthcare resource utilization and direct medical costs associated with index and recurrent
    Feuerstadt P; Stong L; Dahdal DN; Sacks N; Lang K; Nelson WW
    J Med Econ; 2020 Jun; 23(6):603-609. PubMed ID: 31999199
    [No Abstract]   [Full Text] [Related]  

  • 10. Health care Resource Utilization and Migraine Disability Along the Migraine Continuum Among Patients Treated for Migraine.
    Silberstein SD; Lee L; Gandhi K; Fitzgerald T; Bell J; Cohen JM
    Headache; 2018 Nov; 58(10):1579-1592. PubMed ID: 30375650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective database analysis of healthcare resource utilization and costs in patients who develop post-transplant lymphoproliferative disease within the first year following allogeneic hematopoietic stem cell transplants.
    Watson C; Xu H; Princic N; Sruti I; Barlev A
    J Med Econ; 2020 Oct; 23(10):1159-1167. PubMed ID: 32643493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Healthcare utilization and costs among women diagnosed with uterine fibroids: a longitudinal evaluation for 5 years pre- and post-diagnosis.
    Fuldeore M; Yang H; Soliman AM; Winkel C
    Curr Med Res Opin; 2015; 31(9):1719-31. PubMed ID: 26153675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Racial variation in healthcare resource utilization and expenditures in knee/hip osteoarthritis patients: a retrospective analysis of a Medicaid population.
    Silverman S; Packnett E; Zagar A; Thakkar S; Schepman P; Faison W; Hultman C; Zimmerman NM; Robinson RL
    J Med Econ; 2023; 26(1):1047-1056. PubMed ID: 37551123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic Delay of Endometriosis in the Netherlands.
    Staal AH; van der Zanden M; Nap AW
    Gynecol Obstet Invest; 2016; 81(4):321-4. PubMed ID: 26742108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Healthcare utilization and costs of Veterans Health Administration patients with schizophrenia treated with paliperidone palmitate long-acting injection or oral atypical antipsychotics.
    Baser O; Xie L; Pesa J; Durkin M
    J Med Econ; 2015 May; 18(5):357-65. PubMed ID: 25525771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Actuarial analysis of private payer administrative claims data for women with endometriosis.
    Mirkin D; Murphy-Barron C; Iwasaki K
    J Manag Care Pharm; 2007 Apr; 13(3):262-72. PubMed ID: 17407392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health Care Resource Utilization and Cost Before Initial Schizophrenia Diagnosis.
    Wallace A; Barron J; York W; Isenberg K; Franchino-Elder J; Sidovar M; Sand M
    J Manag Care Spec Pharm; 2019 Oct; 25(10):1102-1110. PubMed ID: 31556820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-haul COVID: healthcare utilization and medical expenditures 6 months post-diagnosis.
    Koumpias AM; Schwartzman D; Fleming O
    BMC Health Serv Res; 2022 Aug; 22(1):1010. PubMed ID: 35941617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between glycemic control and diabetes-related hospital costs in patients with type 1 or type 2 diabetes mellitus.
    Menzin J; Korn JR; Cohen J; Lobo F; Zhang B; Friedman M; Neumann PJ
    J Manag Care Pharm; 2010 May; 16(4):264-75. PubMed ID: 20433217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cycling Through Migraine Preventive Treatments: Implications for All-Cause Total Direct Costs and Disease-Specific Costs.
    Ford JH; Schroeder K; Nyhuis AW; Foster SA; Aurora SK
    J Manag Care Spec Pharm; 2019 Jan; 25(1):46-59. PubMed ID: 30044691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.